@dont
Don, as you already know, but others may not, both of these articles that Colleen has placed here on your behalf relate to the antimuscarinic drug pirenzepine, which is being repurposed to help prevent and possibly reverse neuropathy symptoms. The implications for this are pretty exciting. There are trials ongoing, and from what I gather they may be into phase 3 trials by now. The company spearheading the effort, Winsantor, stands to gain tremendously from this if it successfully becomes an FDA approved treatment as there are many millions of people who might potentially become their customers in effect. I for one am hoping for the final breakthrough to happen. With so much to gain for whoever finds the magic bullet it seems like it's only a matter of time when something big is going to come along to help PN sufferers. Hopefully, this is it. Best, Hank